Decisions Home

UK Cell Sorting Market Insight

Published: 19 June 2026   |   Report Format: Electronic (PDF)   |   Author: Govind and Krishna

The United Kingdom Cell Sorting Market is projected to grow at a CAGR of around 8.7%, driven by increasing adoption of advanced cell analysis technologies, rising investments in cell and biopharmaceutical sectors in the United Kingdom.

United Kingdom Cell Sorting Market Forecasts to 2035

  • The United Kingdom Cell Sorting Market size was estimated at approximately USD 210 Million in 2025.
  • The market is expected to grow at a CAGR of around 8.7% from 2025 to 2035.
  • The United Kingdom Cell Sorting Market is projected to reach approximately USD 480 Million by 2035.

Notable Insights for the United Kingdom Cell Sorting Market

  • Segmentation based on technology indicates Fluorescence-Activated Cell Sorting (FACS) accounts for approximately 58% market share in 2025, driven by its high precision and widespread use in biomedical research and clinical applications.
  • Segmentation based on application shows Research Applications holding nearly 45% market share in 2025, supported by increasing studies in immunology, oncology, stem cell biology, and regenerative medicine.
  • The market is led by major companies including Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter Life Sciences), Sony Biotechnology Inc., and Thermo Fisher Scientific Inc., collectively accounting for approximately 60% market share in 2025.
  • Growing investments in cell and gene therapy development have contributed to nearly 38% growth in demand for high-throughput cell sorting solutions over the past five years.

Download the eBook (ToC)

We value your privacy.

Research Methodologies Used to Analyze United Kingdom Cell Sorting Market

The United Kingdom Cell Sorting Market is analyzed using a combination of primary and secondary research methodologies to ensure accurate market estimation, competitive benchmarking, and forecasting. Primary research includes interviews with biotechnology companies, pharmaceutical manufacturers, research institutions, laboratory managers, flow cytometry specialists, and industry experts. Secondary research involves company annual reports, regulatory publications, scientific journals, healthcare databases, industry associations, and market intelligence sources. Data triangulation, demand-supply assessment, and statistical forecasting models are applied to validate market insights and provide reliable forecasts through 2035.

Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making

What is Decisions Advisors Research?

Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in United Kingdom Cell Sorting Market

 

Recent Developments:

 

Market Segmentation:

United Kingdom Cell Sorting Market, By Technology

 

United Kingdom Cell Sorting Market, By Application

 

United Kingdom Cell Sorting Market, By End User

 

Expert Views:

The United Kingdom Cell Sorting Market is expected to witness robust growth through 2035, supported by increasing investments in precision medicine, expanding cell and gene therapy pipelines, and growing demand for advanced cell characterization technologies. Advancements in high-speed sorting systems, automation capabilities, and multi-parameter analysis are anticipated to strengthen long-term market growth across healthcare, biotechnology, and life sciences sectors.


Author: Govind and Krishna By Decisions Advisors and Consulting